Literature DB >> 15101994

Liver transplantation in the era of model for end-stage liver disease.

Victor S Wang1, Sammy Saab.   

Abstract

Liver transplantation is challenged by organ shortage and prolonged waiting list time. The goal of the ideal organ allocation system is to transplant individuals least likely to survive without a liver transplantation, and maintain appropriate rates of postoperative survival. Currently, liver allocation in the United States is based on the model for end-stage liver disease (MELD). Studies have shown MELD to be objective and accurate in predicting short-term survival in patients with cirrhosis.

Entities:  

Mesh:

Year:  2004        PMID: 15101994     DOI: 10.1111/j.1478-3231.2004.00888.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  3 in total

1.  Survival outcomes in liver transplant recipients with Model for End-stage Liver Disease scores of 40 or higher: a decade-long experience.

Authors:  Hina J Panchal; Joel B Durinka; Jeromy Patterson; Farah Karipineni; Sarah Ashburn; Eric Siskind; Jorge Ortiz
Journal:  HPB (Oxford)       Date:  2015-09-16       Impact factor: 3.647

2.  Systemic vascular resistance in cirrhosis: a predictor of severity?

Authors:  Vinaya Gaduputi; Molham Abdulsamad; Sailaja Sakam; Naeem Abbas; Hassan Tariq; Ariyo Ihimoyan
Journal:  Hepat Med       Date:  2014-08-06

3.  Role of MELD score and serum creatinine as prognostic tools for the development of acute kidney injury after liver transplantation.

Authors:  Thiago Gomes Romano; Ivana Schmidtbauer; Fernanda Maria de Queiroz Silva; Carlos Eduardo Pompilio; Luiz Augusto Carneiro D'Albuquerque; Etienne Macedo
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.